12:00 AM
May 19, 2016
 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Catechol-O-methyl-transferase (COMT)


INDICATION: Parkinson's disease (PD)

In vitro studies identified a thiazolidinedione-based COMT inhibitor that could help treat PD. Directed structure-based drug design and in vitro testing identified a thiazolidinedione analog that inhibited...

Read the full 134 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >